Published in Br Heart J on May 01, 1972
Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J (1983) 2.55
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Br Med J (Clin Res Ed) (1986) 2.33
The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease. Br J Clin Pharmacol (1979) 0.83
Platelet reactivity and its dependence on alpha-adrenergic receptor function in patients with ischaemic heart disease. Br Heart J (1983) 0.77
A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone. Postgrad Med J (1987) 0.75
Platelets and coronary disease, round three. Br Med J (Clin Res Ed) (1985) 0.75
Thrombosis: its role and prevention in cardiovascular events--Part I. Concepts of thrombogenesis and its prevention. West J Med (1981) 0.75
Cine coronary arteriography. Mod Concepts Cardiovasc Dis (1962) 7.46
A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA. Circulation (1965) 2.85
Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N Engl J Med (1967) 1.89
Familial factors in premature coronary heart disease--a preliminary report from the Tecumseh Community Health Study. Am J Epidemiol (1970) 1.87
Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55
Abnormalities in platelet behaviour in acute illnesses. Br Med J (1966) 1.31
Nature of the transferable factor which causes abnormal platelet behaviour in vascular disease. Lancet (1967) 1.27
Effect of oral contraceptive agents on platelets and plasma-phospholipids. Lancet (1968) 1.23
Acute myocardial infarction in a nineteen-year-old student in the absence of coronary obstructive disease. N Engl J Med (1970) 1.21
POSTOPERATIVE CHANGES IN PLATELET-CLUMPING ACTIVITY. Lancet (1965) 1.20
A transferable factor causing abnormal platelet behaviour in vascular disease. Lancet (1966) 0.97
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18
Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol (1976) 6.84
The end of clinical freedom. Br Med J (Clin Res Ed) (1983) 6.27
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12
Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet (1988) 4.07
Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet (1988) 4.01
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet (1993) 3.43
Clinical significance of coronary arterial ectasia. Am J Cardiol (1976) 3.43
Audit of coronary angiography and bypass surgery. Lancet (1990) 3.17
Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10
Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation (2000) 2.90
Open access. BMJ (1995) 2.76
Comparison of results from a cardiac ambulance manned by medical or non-medical personnel. Lancet (1977) 2.75
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet (1990) 2.70
Follow-up of emergency ambulance calls in Nottingham: implications for coronary ambulance servie. Br Med J (1975) 2.66
Prospective correlative study of ventricular aneurysm. Mechanistic concept and clinical recognition. Am J Med (1967) 2.56
Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) (1986) 2.55
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53
The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. Am J Med (1973) 2.50
Localized disorders in myocardial contraction. Asynergy and its role in congestive heart failure. N Engl J Med (1967) 2.47
Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J (1992) 2.46
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation (1993) 2.42
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med (1971) 2.40
Randomised trial of a mobile coronary care unit for emergency calls. Br Med J (1978) 2.35
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32
Propranolol and angina pectoris. Am J Cardiol (1966) 2.32
Prognosis of patients with "chest pain ?cause". Br Med J (Clin Res Ed) (1981) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
The nature and course of depression following myocardial infarction. Arch Intern Med (1989) 2.19
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Mode of referral to hospital of patients with heart attacks: relevance to home care and special ambulance services. Br Med J (1976) 2.04
Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes (1978) 2.04
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Air travel and thrombotic episodes: the economy class syndrome. Lancet (1988) 1.93
Advanced training for ambulance crews: implications from 403 consecutive patients with cardiac arrest managed by crews with simple training. Br Med J (Clin Res Ed) (1987) 1.92
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90
Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation (1996) 1.86
Presentation and analysis of the results of clinical trials in cardiovascular disease. Br Med J (Clin Res Ed) (1981) 1.86
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Myocardial revascularization with internal mammary artery implantation: current status. JAMA (1969) 1.84
Implications of left ventricular asynergy. Am J Cardiol (1969) 1.83
Diagnostic criteria for myocardial infarction. Br J Hosp Med (1981) 1.82
The anginal syndrome with normal coronary arteriography. Trans Assoc Am Physicians (1967) 1.81
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol (1993) 1.80
A hemodynamic study of left ventricular aneurysm. Circulation (1967) 1.80
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart (1999) 1.76
Simple training programme for ambulance personnel in the management of cardiac arrest in the community. Br Med J (Clin Res Ed) (1985) 1.74
Neurological presentation of bacterial endocarditis. Br Med J (1967) 1.70
Cardiovascular pharmacology of propranolol in man. Circulation (1969) 1.69
Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol (1985) 1.68
Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease. Am J Cardiol (1974) 1.67
Differences in drug treatment of chronic heart failure between European countries. Eur Heart J (1999) 1.63
Modified orifice equation for the calculation of mitral valve area. Am Heart J (1972) 1.60
The National Service Framework for coronary heart disease: the emperor's new clothes. J R Coll Physicians Lond (2000) 1.60
Coronary heart disease. Clinical, cinearteriographic and metabolic correlations. Am J Cardiol (1966) 1.57
Comparison of mortality of patients with heart attacks admitted to a coronary care unit and an ordinary medical ward. Br Med J (1977) 1.57
Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55
Physicians' reactions to patients. A key to teaching humanistic medicine. N Engl J Med (1983) 1.54
Functional importance of the human coronary collateral circulation. N Engl J Med (1971) 1.52
The health of the nation's research and development. BMJ (1993) 1.52
Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J (1979) 1.50
Main left coronary artery disease. Clinical experience from 1964-1974. Circulation (1975) 1.49
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Angiographic patterns of balloon inflation during percutaneous transluminal coronary angioplasty: role of pressure-diameter curves in studying distensibility and elasticity of the stenotic lesion and the mechanism of dilation. J Am Coll Cardiol (1990) 1.49
Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register. QJM (1995) 1.47
Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol (1985) 1.46
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am J Cardiol (1969) 1.45
The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects. N Engl J Med (1973) 1.43
A generalized formulation of the Gorlin formula for calculating the area of the stenotic mitral valve and other stenotic cardiac valves. J Am Coll Cardiol (1990) 1.41
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. Br Med J (1979) 1.41
Subaortic stenosis: a reviewed concept of the disease. 1959. Medicine (Baltimore) (1993) 1.39
The limited potential of special ambulance services in the management of cardiac arrest. Br Heart J (1990) 1.39
Captopril therapy for heart failure. A placebo controlled study. Lancet (1982) 1.39
Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res (1970) 1.38
Physiologic Evaluation of Patients with Mitral Stenosis before and After Mitral Valvuloplasty. Trans Am Clin Climatol Assoc (1950) 1.38
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med (1968) 1.38
Progression of coronary artery disease. A clinical arteriographic study. Circulation (1973) 1.37
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation (1979) 1.35
An electrocardiographic, anatomic, and metabolic study of zonal myocardial ischemia in coronary heart disease. Circulation (1967) 1.34
Mechanisms of angina in aortic stenosis. Circulation (1967) 1.34
Cardiovascular control in diabetes mellitus. Br Med J (1975) 1.34
Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts. J Med Genet (2002) 1.33
Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res (1967) 1.32
Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry (1976) 1.31
Abnormalities in platelet behaviour in acute illnesses. Br Med J (1966) 1.31
Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Br Med J (Clin Res Ed) (1986) 1.31
Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients. J Am Coll Cardiol (1987) 1.30
Detection and sizing of acute myocardial infarcts with 99mTc (Sn) tetracycline. N Engl J Med (1974) 1.28
Comparison of mobilization after two and nine days in uncomplicated myocardial infarction. Br Med J (1974) 1.27
Nature of the transferable factor which causes abnormal platelet behaviour in vascular disease. Lancet (1967) 1.27
Cardiovascular reflex responses to apnoeic face immersion and mental stress in diabetic subjects. Cardiovasc Res (1976) 1.27
Survey of general practitioners' attitudes to management of patients with heart attacks. Br Med J (1975) 1.26
Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation (1974) 1.25
Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials. Br Med J (Clin Res Ed) (1982) 1.25